Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 21, 2005
The economic burden of drug resistance
David H Howard, R Douglas Scott
Emerging Infectious Diseases
|
August 25, 2004
Collecting data to assess SARS interventions
R Douglas Scott, Edward Gregg, Martin I Meltzer
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society
|
March 1, 2019
Understanding the Economic Impact of Health Care-Associated Infections: A Cost Perspective Analysis
R Douglas Scott, Steven D Culler, Kimberly J Rask
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2003
The global impact of drug resistance
David H Howard, R Douglas Scott, Randall Packard, et al.
Pediatrics
|
May 4, 2005
Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
Colin W Shepard, Ismael R Ortega-Sanchez, R Douglas Scott, et al.
American Journal of Preventive Medicine
|
July 18, 2002
Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis
R Douglas Scott, Martin I Meltzer, Lonny J Erickson, et al.
Infection Control and Hospital Epidemiology
|
March 19, 2015
The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program
Rachel B Slayton, R Douglas Scott, James Baggs, et al.
Emerging Infectious Diseases
|
October 27, 2004
West Nile virus economic impact, Louisiana, 2002
Armineh Zohrabian, Martin I Meltzer, Raoult Ratard, et al.
Antimicrobial Resistance and Infection Control
|
January 26, 2019
Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent <i>Clostridioides difficile</i> infection in US hospitals
R Douglas Scott, Rachel B Slayton, Fernanda C Lessa, et al.
Health Affairs (Project Hope)
|
June 4, 2014
CDC central-line bloodstream infection prevention efforts produced net benefits of at least $640 Million during 1990-2008
R Douglas Scott, Ronda Sinkowitz-Cochran, Matthew E Wise, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 21, 2005
The economic burden of drug resistance
David H Howard, R Douglas Scott
Emerging Infectious Diseases
|
August 25, 2004
Collecting data to assess SARS interventions
R Douglas Scott, Edward Gregg, Martin I Meltzer
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society
|
March 1, 2019
Understanding the Economic Impact of Health Care-Associated Infections: A Cost Perspective Analysis
R Douglas Scott, Steven D Culler, Kimberly J Rask
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 8, 2003
The global impact of drug resistance
David H Howard, R Douglas Scott, Randall Packard, et al.
Pediatrics
|
May 4, 2005
Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
Colin W Shepard, Ismael R Ortega-Sanchez, R Douglas Scott, et al.
American Journal of Preventive Medicine
|
July 18, 2002
Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis
R Douglas Scott, Martin I Meltzer, Lonny J Erickson, et al.
Infection Control and Hospital Epidemiology
|
March 19, 2015
The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program
Rachel B Slayton, R Douglas Scott, James Baggs, et al.
Emerging Infectious Diseases
|
October 27, 2004
West Nile virus economic impact, Louisiana, 2002
Armineh Zohrabian, Martin I Meltzer, Raoult Ratard, et al.
Antimicrobial Resistance and Infection Control
|
January 26, 2019
Assessing the social cost and benefits of a national requirement establishing antibiotic stewardship programs to prevent <i>Clostridioides difficile</i> infection in US hospitals
R Douglas Scott, Rachel B Slayton, Fernanda C Lessa, et al.
Health Affairs (Project Hope)
|
June 4, 2014
CDC central-line bloodstream infection prevention efforts produced net benefits of at least $640 Million during 1990-2008
R Douglas Scott, Ronda Sinkowitz-Cochran, Matthew E Wise, et al.
Page
of 2